Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 7;7(8):ofaa329.
doi: 10.1093/ofid/ofaa329. eCollection 2020 Aug.

PrEP Nonadherence, White Coat Dosing, and HIV Risk Among a Cohort of MSM

Affiliations

PrEP Nonadherence, White Coat Dosing, and HIV Risk Among a Cohort of MSM

Cheríe S Blair et al. Open Forum Infect Dis. .

Abstract

Among a cohort of men who have sex with men in a pre-exposure prophylaxis (PrEP) adherence trial, syphilis requiring treatment was associated with white coat dosing (increased PrEP adherence immediately preceding study visits) when compared with participants with optimal drug concentrations. The findings highlight the need for identifying and reducing barriers to PrEP adherence.

Keywords: MSM; PrEP adherence; pre-exposure prophylaxis; syphilis; white coat dosing.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Frequency of HIV risk behaviors and syphilis requiring treatment with optimal, suboptimal, and white coat dosing concentrations at study visits among a cohort of men who have sex with men using PrEP (n = 1254). Syphilis was screened at each study visit and defined as a positive RPR titer with positive TPPA confirmation (if previous titer negative) and/or 4-fold increase in RPR from historical titers. aLast 30 days. bBefore intercourse. cP ≤ .001. dP ≤ .05. Abbreviations: CAI, condomless anal intercourse; PrEP, pre-exposure prophylaxis; RPR, rapid plasma regain; TPPA, Treponema pallidum particle agglutination assay.

References

    1. Anderson PL, Glidden DV, Liu A, et al. ; iPrEx Study Team Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med 2012; 4:151ra125. - PMC - PubMed
    1. Grant RM, Anderson PL, McMahan V, et al. ; iPrEx study team Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis 2014; 14:820–9. - PMC - PubMed
    1. Castillo-Mancilla JR, Haberer JE. Adherence measurements in HIV: new advancements in pharmacologic methods and real-time monitoring. Curr HIV/AIDS Rep 2018; 15:49–59. - PMC - PubMed
    1. Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990; 150:1377–8. - PubMed
    1. Podsadecki TJ, Vrijens BC, Tousset EP, et al. . “White coat compliance” limits the reliability of therapeutic drug monitoring in HIV-1-infected patients. HIV Clin Trials 2008; 9:238–46. - PubMed